Search Results for: CTNNB1

Novel Interactant Symbol Name
Associated Pathways
Binding Drugs
Associated Diseases
BCL9L BCL9 like
  • Formation of the beta-catenin:TCF transactivating complex
  • Deactivation of the beta-catenin transactivating complex
BOC BOC cell adhesion associated, oncogene regulated
  • Ligand-receptor interactions
  • Activation of SMO
CA9 carbonic anhydrase 9
  • Regulation of gene expression by Hypoxia-inducible Factor
  • Reversible hydration of carbon dioxide
  • Benzthiazide
  • Benzthiazide
  • Cyclothiazide
  • Hydroflumethiazide
  • Zonisamide
  • Girentuximab
  • Ellagic acid
  • Sodium carbonate
CDH5 cadherin 5
  • Adherens junctions interactions
  • VEGFR2 mediated vascular permeability
  • Lenalidomide
  • FX06
DSC3 desmocollin 3
  • Keratinization
  • Formation of the cornified envelope
  • Hypotrichosis and recurrent skin vesicles
ELAVL1 ELAV like RNA binding protein 1
  • HuR (ELAVL1) binds and stabilizes mRNA
  • mRNA Splicing - Major Pathway
FLT1 fms related receptor tyrosine kinase 1
  • Neurophilin interactions with VEGF and VEGFR
  • VEGF binds to VEGFR leading to receptor dimerization
  • Sorafenib
  • Sunitinib
  • Vatalanib
  • TG-100801
  • OSI-930
  • Denibulin
  • ABT-869
  • IMC-1C11
  • Pazopanib
  • Axitinib
  • N-(4-chlorophenyl)-2-[(pyridin-4-ylmethyl)amino]benzamide
  • Regorafenib
  • Lenvatinib
  • Nintedanib
  • Polaprezinc
  • Foreskin fibroblast (neonatal)
  • Fostamatinib
  • Selpercatinib
GRIK2 glutamate ionotropic receptor kainate type subunit 2
  • Activation of Na-permeable kainate receptors
  • Activation of Ca-permeable Kainate Receptor
  • Glutamic acid
  • Butabarbital
  • Butalbital
  • Topiramate
  • Talbutal
  • Pentobarbital
  • Secobarbital
  • Metharbital
  • Thiopental
  • Primidone
  • Methylphenobarbital
  • Phenobarbital
  • Amobarbital
  • Aprobarbital
  • Butobarbital
  • Heptabarbital
  • Hexobarbital
  • Barbital
  • Dihydro-2-thioxo-5-((5-(2-(trifluoromethyl)phenyl)-2-furanyl)methyl)-4,6(1H,5H)-pyrimidinedione
  • Domoic Acid
  • Quisqualic acid
  • 2s,4r-4-Methylglutamate
  • Nonsyndromic autosomal recessive mental retardation (NS-ARMR)
H1-2 H1.2 linker histone, cluster member
  • Apoptosis induced DNA fragmentation
  • Formation of Senescence-Associated Heterochromatin Foci (SAHF)
HUWE1 HECT, UBA and WWE domain containing E3 ubiquitin protein ligase 1
  • Neutrophil degranulation
  • Antigen processing: Ubiquitination & Proteasome degradation
  • Syndromic X-linked mental retardation, including: Turner type (MRXST); Siderius type (MRXSSD) ; Cabezas type (MRXC); Raymond type (MRXSR); Type10 (MRXS10); Type14 (MRXS14); Mental retardation with isolated growth hormone deficiency (MRGH)
IGF2BP1 insulin like growth factor 2 mRNA binding protein 1
  • Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA
  • MAPK6/MAPK4 signaling
NF2 neurofibromin 2
  • Regulation of actin dynamics for phagocytic cup formation
  • RHO GTPases activate PAKs
  • Malignant pleural mesothelioma
  • Noonan syndrome and related disorders, including: Noonan syndrome (NS); Leopard syndrome (LS); Noonan syndrome-like with loose anagen hair (NS/LAH); CBL-mutation associated syndrome (CBL); Neurofibromatosis type 1 (NF1); Neurofibromatosis type 2 (NF2); Neurofibromatosis-Noonan syndrome (NFNS); Legius syndrome; Cardiofaciocutaneous syndrome (CFCS); Costello syndrome (CS)
PICK1 protein interacting with PRKCA 1
  • Cell surface interactions at the vascular wall
  • Trafficking of GluR2-containing AMPA receptors
PKD1 polycystin 1, transient receptor potential channel interacting
  • VxPx cargo-targeting to cilium
  • VxPx cargo-targeting to cilium
  • Polycystic kidney disease
PKP2 plakophilin 2
  • Keratinization
  • Formation of the cornified envelope
  • Arrhythmogenic right ventricular cardiomyopathy (ARVC)
PPM1A protein phosphatase, Mg2+/Mn2+ dependent 1A
  • Downregulation of SMAD2/3:SMAD4 transcriptional activity
  • Energy dependent regulation of mTOR by LKB1-AMPK
PTPN13 protein tyrosine phosphatase non-receptor type 13
  • Synthesis of PIPs at the plasma membrane
  • Interleukin-37 signaling
PTPRF protein tyrosine phosphatase receptor type F
  • Receptor-type tyrosine-protein phosphatases
  • Synaptic adhesion-like molecules
PYGO1 pygopus family PHD finger 1
  • Formation of the beta-catenin:TCF transactivating complex
  • Deactivation of the beta-catenin transactivating complex
RUVBL2 RuvB like AAA ATPase 2
  • Telomere Extension By Telomerase
  • HATs acetylate histones
  • Quercetin

Page 7 out of 10 pages